臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)

???ui.leftmenu.abouttair???
	???ui.leftmenu.explanation???

???ui.leftmenu.bartitle???
	Repositories
	Author
	Title
	Date
	???ui.leftmenu.statisticschart???
	???ui.leftmenu.realtimefacts???
	???ui.leftmenu.trend???

???index.news???
	2019臺灣學術機構典藏研討會
	機構典藏系統RC7版本已發佈

???ui.leftmenu.copyrighttitle???
	???ui.leftmenu.copyrightpublisher???
	???ui.leftmenu.copyrightconference???

???ui.leftmenu.link???
	機構典藏計畫網站
	ROAR
	OpenDOAR
	SHERPA
	OAIster
	JAIRO
	Ira
	DSPACE
	RWWR
	臺大學術典藏NTU Scholars

"vogelzang n j"???jsp.browse.items-by-author.description???

???jsp.browse.items-by-author.back???
???jsp.browse.items-by-author.order1???	???jsp.browse.items-by-author.order2???

Showing items 1-20 of 20 (1 Page(s) Totally)
1
View [10|25|50] records per page

Institution	Date	Title	Author
臺大學術典藏	2022-09-15T01:09:56Z	Weekly cisplatin plus infusional high-dose 5-fluorouracil and leucovorin (P-HDFL) for metastatic urothelial carcinoma: An effective regimen with low toxicity	Chia-Chi Lin; Hsu C.-H.; Huang C.-Y.; Cheng A.-L.; Chen J.; Vogelzang N.J.; Pu Y.-S.
臺大學術典藏	2022-09-15T01:09:56Z	Phase II Trial of Weekly Paclitaxel, Cisplatin Plus Infusional High Dose 5-Fluorouracil and Leucovorin for Metastatic Urothelial Carcinoma	Chia-Chi Lin; Hsu C.-H.; Huang C.-Y.; Cheng A.-L.; Vogelzang N.J.; Pu Y.-S.
臺大學術典藏	2022-09-15T01:09:52Z	Systemic therapy for metastatic urothelial carcinoma	Chia-Chi Lin; Hsu C.-H.; Pu Y.-S.; Vogelzang N.J.
臺大學術典藏	2021-10-14T02:46:18Z	Weekly cisplatin plus infusional high-dose 5-fluorouracil and leucovorin (P-HDFL) for metastatic urothelial carcinoma: An effective regimen with low toxicity	Lin C.-C.; Hsu C.-H.; CHAO-YUAN HUANG; Cheng A.-L.; Chen J.; Vogelzang N.J.; Pu Y.-S.
臺大學術典藏	2021-10-14T02:46:17Z	Phase II Trial of Weekly Paclitaxel, Cisplatin Plus Infusional High Dose 5-Fluorouracil and Leucovorin for Metastatic Urothelial Carcinoma	Lin C.-C.; Hsu C.-H.; CHAO-YUAN HUANG; Cheng A.-L.; Vogelzang N.J.; Pu Y.-S.
臺大學術典藏	2021-10-14T02:45:34Z	Optimal usage of radium-223 in metastatic castration-resistant prostate cancer	Cha T.-L.; Wu T.T.-L.; Vogelzang N.J.; CHAO-YUAN HUANG; Huang S.-P.; Lin C.-C.; Ou Y.-C.; Pang S.-T.; Shen D.H.-Y.; Wu W.-J.; Chang W.Y.-H.
臺大學術典藏	2021-09-01T02:02:11Z	Weekly cisplatin plus infusional high-dose 5-fluorouracil and leucovorin (P-HDFL) for metastatic urothelial carcinoma: An effective regimen with low toxicity	Lin C.-C.; Hsu C.-H.; Huang C.-Y.; ANN-LII CHENG; Chen J.; Vogelzang N.J.; Pu Y.-S.
臺大學術典藏	2021-09-01T02:02:09Z	Phase II Trial of Weekly Paclitaxel, Cisplatin Plus Infusional High Dose 5-Fluorouracil and Leucovorin for Metastatic Urothelial Carcinoma	Lin C.-C.; Hsu C.-H.; Huang C.-Y.; ANN-LII CHENG; Vogelzang N.J.; Pu Y.-S.
臺大學術典藏	2021-02-02T00:47:00Z	Weekly cisplatin plus infusional high-dose 5-fluorouracil and leucovorin (P-HDFL) for metastatic urothelial carcinoma: An effective regimen with low toxicity	Lin C.-C.;Hsu C.-H.;Huang C.-Y.;Cheng A.-L.;Chen J.;Vogelzang N.J.;Yeong-Shiau Pu; Lin C.-C.; Hsu C.-H.; Huang C.-Y.; Cheng A.-L.; Chen J.; Vogelzang N.J.; YEONG-SHIAU PU
臺大學術典藏	2021-02-02T00:46:59Z	Phase II Trial of Weekly Paclitaxel, Cisplatin Plus Infusional High Dose 5-Fluorouracil and Leucovorin for Metastatic Urothelial Carcinoma	Lin C.-C.;Hsu C.-H.;Huang C.-Y.;Cheng A.-L.;Vogelzang N.J.;Yeong-Shiau Pu; Lin C.-C.; Hsu C.-H.; Huang C.-Y.; Cheng A.-L.; Vogelzang N.J.; YEONG-SHIAU PU
臺大學術典藏	2021-02-02T00:46:53Z	Systemic therapy for metastatic urothelial carcinoma	Lin C.-C.; Hsu C.-H.; YEONG-SHIAU PU; Vogelzang N.J.
臺大學術典藏	2020-05-25T07:35:34Z	Weekly cisplatin plus infusional high-dose 5-fluorouracil and leucovorin (P-HDFL) for metastatic urothelial carcinoma: An effective regimen with low toxicity	Pu Y.-S.;Vogelzang N.J;Chen J;Cheng A.-L;Huang C.-Y;Hsu C.-H;Chia-Chi Lin; Chia-Chi Lin; Hsu C.-H; Huang C.-Y; Cheng A.-L; Chen J; Vogelzang N.J; Pu Y.-S.
臺大學術典藏	2020-05-25T07:35:34Z	Weekly cisplatin plus infusional high-dose 5-fluorouracil and leucovorin (P-HDFL) for metastatic urothelial carcinoma: An effective regimen with low toxicity	Pu Y.-S.;Vogelzang N.J;Chen J;Cheng A.-L;Huang C.-Y;Hsu C.-H;Chia-Chi Lin; Chia-Chi Lin; Hsu C.-H; Huang C.-Y; Cheng A.-L; Chen J; Vogelzang N.J; Pu Y.-S.
臺大學術典藏	2020-05-25T07:35:33Z	Phase II Trial of Weekly Paclitaxel, Cisplatin Plus Infusional High Dose 5-Fluorouracil and Leucovorin for Metastatic Urothelial Carcinoma	Chia-Chi Lin; Hsu C.-H; Huang C.-Y; Cheng A.-L; Vogelzang N.J; Pu Y.-S.
臺大學術典藏	2020-05-25T07:35:32Z	Systemic therapy for metastatic urothelial carcinoma	Chia-Chi Lin; Hsu C.-H; Pu Y.-S; Vogelzang N.J.
臺大學術典藏	2020-05-25T07:35:26Z	Cabozantinib in patients with advanced prostate cancer: Results of a phase II randomized discontinuation trial	Smith D.C; Smith M.R; Sweeney C; Elfiky A.A; Logothetis C; Corn P.G; Vogelzang N.J; Small E.J; Harzstark A.L; Gordon M.S; Vaishampayan U.N; Haas N.B; Spira A.I; Lara Jr. P.N; Chia-Chi Lin; Srinivas S; Sella A; Sch?ffski P; Scheffold C; Weitzman A.L; Hussain M.
臺大學術典藏	2020-05-25T07:35:24Z	An open-label, single-arm, phase 2 trial of the polo-like kinase inhibitor volasertib (BI 6727) in patients with locally advanced or metastatic urothelial cancer	Stadler W.M; Vaughn D.J; Sonpavde G; Vogelzang N.J; Tagawa S.T; Petrylak D.P; Rosen P; Chia-Chi Lin; Mahoney J; Modi S; Lee P; Ernstoff M.S; Su W.-C; Spira A; Pilz K; Vinisko R; Schloss C; Fritsch H; Zhao C; Carducci M.A.
臺大學術典藏	2020-05-25T07:35:14Z	Optimal usage of radium-223 in metastatic castration-resistant prostate cancer	Cha T.-L; Wu T.T.-L; Vogelzang N.J; Huang C.-Y; Huang S.-P; Chia-Chi Lin; Ou Y.-C; Pang S.-T; Shen D.H.-Y; Wu W.-J; Chang W.Y.-H.
臺大學術典藏	2020-04-28T07:25:34Z	Weekly cisplatin plus infusional high-dose 5-fluorouracil and leucovorin (P-HDFL) for metastatic urothelial carcinoma: An effective regimen with low toxicity	Lin C.-C.;Chih-Hung Hsu;Huang C.-Y.;Cheng A.-L.;Chen J.;Vogelzang N.J.;Pu Y.-S.; Lin C.-C.; CHIH-HUNG HSU; Huang C.-Y.; Cheng A.-L.; Chen J.; Vogelzang N.J.; Pu Y.-S.
臺大學術典藏	2020-04-28T07:25:34Z	Weekly cisplatin plus infusional high-dose 5-fluorouracil and leucovorin (P-HDFL) for metastatic urothelial carcinoma: An effective regimen with low toxicity	Lin C.-C.;Chih-Hung Hsu;Huang C.-Y.;Cheng A.-L.;Chen J.;Vogelzang N.J.;Pu Y.-S.; Lin C.-C.; CHIH-HUNG HSU; Huang C.-Y.; Cheng A.-L.; Chen J.; Vogelzang N.J.; Pu Y.-S.

Showing items 1-20 of 20 (1 Page(s) Totally)
1
View [10|25|50] records per page

	English \| 正體中文 \| 简体中文 \| 2818311
	???header.visitor??? : 28024851 ???header.onlineuser??? : 461 ???header.sponsordeclaration???